Skip to main content
Clinical Trials/NL-OMON53314
NL-OMON53314
Recruiting
Not Applicable

ARC Therapy to restore hemodynamic stability and trunk control in people with spinal cord injury - HemON

ONWARD Medical0 sites8 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
epidural lesion
Sponsor
ONWARD Medical
Enrollment
8
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
ONWARD Medical

Eligibility Criteria

Inclusion Criteria

  • \- 18 years of age or older
  • \- Must provide and sign the Informed Consent prior to any study\-related
  • \- Traumatic spinal cord injury
  • \- Spinal cord injury lesion level between C3 and T6 (inclusive)
  • \- AIS\- A, B, C or D
  • \- SCI \>\= 1month
  • \- Confirmed orthostatic hypotension
  • \- Stable medical, physical and psychological condition as considered by the
  • investigators
  • \- Able to understand and interact with the study team in Dutch or English

Exclusion Criteria

  • \- Diseases and conditions that would increase the morbidity and mortality of
  • spinal cord injury surgery
  • \- The inability to withhold antiplatelet/anticoagulation agents perioperatively
  • \- History of myocardial infarction or cerebrovascular event within the past 6
  • \- Other conditions that would make the subject unable to participate in testing
  • in the judgement of the investigators
  • \- Clinically significant mental illness in the judgement of the investigators
  • \- Botulinum toxin non\-vesical and vesical injections in the previous 3 months
  • before the enrolment
  • \- Presence of significant pressure ulcers

Outcomes

Primary Outcomes

Not specified

Similar Trials